Hemodynamic Effects of Dopamine Versus Norepinephrine Under General Anesthesia in Infant With Congenital Heart Disease

A new strategy for hemodynamic management under anesthesia in children with congenital heart disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037543

Enrollment

Unknown

Registered

2020-08-28

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease

Interventions

Norepinephrine Group:Norepinephrine

Dopamine Group:Dopamine

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Receive cardiac surgery under general anesthesia for congenital heart disease, aged 3 to 12 months

Exclusion criteria

Exclusion criteria: Aortic valve or aortic disease, severe arrhythmia, use of cardiovascular active drugs before anesthesia, failure of arterial puncture and catheterization after anesthesia, need to use a combination of different cardiovascular support drugs after anesthesia

Design outcomes

Primary

Measure	Time frame
changes of cardiac index ;	—

Secondary

Measure	Time frame
changes of stroke volume index;changes of systemic vascular resistance index ;changes of the maximal slope of systolic upstroke ;changes of heart rate;	—

Countries

China

Contacts

Public ContactZhou Zhijian

Children's Hospital of Fudan University

zhou-wuya@163.com+86 18017590815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026